Recent

% | $
Quotes you view appear here for quick access.

BioCryst Pharmaceuticals, Inc. Message Board

  • chuckitchuck chuckitchuck Apr 5, 2013 7:13 PM Flag

    China's CIDRAP News: H7N9 is sensitive to neuraminidase inhibitors

    Antigenic and genome sequencing suggests that H7N9 is sensitive to neuraminidase inhibitors, and the drug's use in early infection appears to be effective, but more research is needed to determine if the treatment's benefits are specific to H7N9 infection, China's CDC said.

    Per company website pipeline: BCRX's FDA approved drug "Peramivir Outpatient Flu" is a viral neuraminidase inhibitor for the treatment of influenza.

 
BCRX
14.93+0.51(+3.54%)Jun 30 4:00 PMEDT